Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1

English version České info

Abnormal phosphorylation and toxicity of a microtubule-associated protein tau are involved in the pathogenesis of Alzheimer's disease (AD); however, what pathological conditions trigger tau abnormality in AD is not fully understood. A reduction in the number of mitochondria in the axon has been implicated in AD. In this study, we investigated whether and how loss of axonal mitochondria promotes tau phosphorylation and toxicity in vivo. Using transgenic Drosophila expressing human tau, we found that RNAi–mediated knockdown of milton or Miro, an adaptor protein essential for axonal transport of mitochondria, enhanced human tau-induced neurodegeneration. Tau phosphorylation at an AD–related site Ser262 increased with knockdown of milton or Miro; and partitioning defective-1 (PAR-1), the Drosophila homolog of mammalian microtubule affinity-regulating kinase, mediated this increase of tau phosphorylation. Tau phosphorylation at Ser262 has been reported to promote tau detachment from microtubules, and we found that the levels of microtubule-unbound free tau increased by milton knockdown. Blocking tau phosphorylation at Ser262 site by PAR-1 knockdown or by mutating the Ser262 site to unphosphorylatable alanine suppressed the enhancement of tau-induced neurodegeneration caused by milton knockdown. Furthermore, knockdown of milton or Miro increased the levels of active PAR-1. These results suggest that an increase in tau phosphorylation at Ser262 through PAR-1 contributes to tau-mediated neurodegeneration under a pathological condition in which axonal mitochondria is depleted. Intriguingly, we found that knockdown of milton or Miro alone caused late-onset neurodegeneration in the fly brain, and this neurodegeneration could be suppressed by knockdown of Drosophila tau or PAR-1. Our results suggest that loss of axonal mitochondria may play an important role in tau phosphorylation and toxicity in the pathogenesis of AD.

Vyšlo v časopise: Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1. PLoS Genet 8(8): e32767. doi:10.1371/journal.pgen.1002918
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002918

Souhrn

Zdroje

1. WangX, SchwarzTL (2009) The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell 136: 163–174.

2. DuncanJE, GoldsteinLS (2006) The genetics of axonal transport and axonal transport disorders. PLoS Genet 2: e124 doi:10.1371/journal.pgen.0020124.

3. WangX, SuB, LeeHG, LiX, PerryG, et al. (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29: 9090–9103.

4. StokinGB, LilloC, FalzoneTL, BruschRG, RockensteinE, et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307: 1282–1288.

5. ChoDH, NakamuraT, FangJ, CieplakP, GodzikA, et al. (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324: 102–105.

6. ZhaoXL, WangWA, TanJX, HuangJK, ZhangX, et al. (2010) Expression of beta-amyloid Induced age-dependent presynaptic and axonal changes in Drosophila. J Neurosci 30: 1512–1522.

7. Iijima-AndoK, HearnSA, ShentonC, GattA, ZhaoL, et al. (2009) Mitochondrial Mislocalization Underlies Aβ42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer's Disease. PLoS ONE 4: e8310 doi:10.1371/journal.pone.0008310.

8. RuiY, TiwariP, XieZ, ZhengJQ (2006) Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 26: 10480–10487.

9. VosselKA, ZhangK, BrodbeckJ, DaubAC, SharmaP, et al. (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330: 198.

10. ZempelH, ThiesE, MandelkowE, MandelkowEM (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30: 11938–11950.

11. StoothoffW, JonesPB, Spires-JonesTL, JoynerD, ChhabraE, et al. (2009) Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J Neurochem 111: 417–427.

12. CheeFC, MudherA, CuttleMF, NewmanTA, MacKayD, et al. (2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis 20: 918–928.

13. DubeyM, ChaudhuryP, KabiruH, SheaTB (2008) Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability. Cell Motil Cytoskeleton 65: 89–99.

14. QuintanillaRA, Matthews-RobersonTA, DolanPJ, JohnsonGV (2009) Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J Biol Chem 284: 18754–18766.

15. LeeVM, GoedertM, TrojanowskiJQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121–1159.

16. AugustinackJC, SchneiderA, MandelkowEM, HymanBT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103: 26–35.

17. HollenbeckPJ, SaxtonWM (2005) The axonal transport of mitochondria. J Cell Sci 118: 5411–5419.

18. GuoX, MacleodGT, WellingtonA, HuF, PanchumarthiS, et al. (2005) The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47: 379–393.

19. GlaterEE, MegeathLJ, StowersRS, SchwarzTL (2006) Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol 173: 545–557.

20. FranssonS, RuusalaA, AspenstromP (2006) The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem Biophys Res Commun 344: 500–510.

21. StowersRS, MegeathLJ, Gorska-AndrzejakJ, MeinertzhagenIA, SchwarzTL (2002) Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36: 1063–1077.

22. WittmannCW, WszolekMF, ShulmanJM, SalvaterraPM, LewisJ, et al. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293: 711–714.

23. BrandAH, PerrimonN (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415.

24. StamerK, VogelR, ThiesE, MandelkowE, MandelkowEM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156: 1051–1063.

25. Gorska-AndrzejakJ, StowersRS, BoryczJ, KostylevaR, SchwarzTL, et al. (2003) Mitochondria are redistributed in Drosophila photoreceptors lacking milton, a kinesin-associated protein. J Comp Neurol 463: 372–388.

26. LiuS, SawadaT, LeeS, YuW, SilverioG, et al. (2012) Parkinson's Disease-Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria. PLoS Genet 8: e1002537 doi:10.1371/journal.pgen.1002537.

27. JacksonGR, Wiedau-PazosM, SangT-K, WagleN, BrownCA, et al. (2002) Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila. Neuron 34: 509–519.

28. ShulmanJM, FeanyMB (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165: 1233–1242.

29. BlardO, FeuilletteS, BouJ, ChaumetteB, FrebourgT, et al. (2007) Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum Mol Genet 16: 555–566.

30. AmbegaokarSS, JacksonGR (2011) Functional Genomic Screen and Network Analysis Reveal Novel Modifiers of Tauopathy Dissociated from Tau Phosphorylation. Hum Mol Genet 20: 4947–4977.

31. GotzJ, GladbachA, PennanenL, van EerselJ, SchildA, et al. (2010) Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta 1802: 860–871.

32. BiernatJ, GustkeN, DrewesG, MandelkowEM, MandelkowE (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11: 153–163.

33. DrewesG, TrinczekB, IllenbergerS, BiernatJ, Schmitt-UlmsG, et al. (1995) Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem 270: 7679–7688.

34. MarxA, NugoorC, PanneerselvamS, MandelkowE (2010) Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases. FASEB J 24: 1637–1648.

35. NishimuraI, YangY, LuB (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116: 671–682.

36. Iijima-AndoK, ZhaoL, GattA, ShentonC, IijimaK (2010) A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration. Hum Mol Genet 19: 1930–1938.

37. WangJW, ImaiY, LuB (2007) Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J Neurosci 27: 574–581.

38. FangY, SoaresL, TengX, GearyM, BoniniNM (2012) A Novel Drosophila Model of Nerve Injury Reveals an Essential Role of Nmnat in Maintaining Axonal Integrity. Curr Biol 10.1016/j.cub.2012.01.065.

39. HeidaryG, FortiniME (2001) Identification and characterization of the Drosophila tau homolog. Mech Dev 108: 171–178.

40. SofolaO, KerrF, RogersI, KillickR, AugustinH, et al. (2010) Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet 6: e1001087 doi:10.1371/journal.pgen.1001087.

41. MershinA, PavlopoulosE, FitchO, BradenBC, NanopoulosDV, et al. (2004) Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons. Learn Mem 11: 277–287.

42. UbhiKK, ShaibahH, NewmanTA, ShepherdD, MudherA (2007) A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Invert Neurosci 7: 165–171.

43. ChenX, LiY, HuangJ, CaoD, YangG, et al. (2007) Study of tauopathies by comparing Drosophila and human tau in Drosophila. Cell Tissue Res 329: 169–178.

44. NicollJA, WilkinsonD, HolmesC, SteartP, MarkhamH, et al. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9: 448–452.

45. LewisJ, DicksonDW, LinWL, ChisholmL, CorralA, et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487–1491.

46. GotzJ, ChenF, van DorpeJ, NitschRM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293: 1491–1495.

47. OddoS, CaccamoA, ShepherdJD, MurphyMP, GoldeTE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409–421.

48. OddoS, BillingsL, KesslakJP, CribbsDH, LaFerlaFM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43: 321–332.

49. RapoportM, DawsonHN, BinderLI, VitekMP, FerreiraA (2002) Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99: 6364–6369.

50. KingME, KanHM, BaasPW, ErisirA, GlabeCG, et al. (2006) Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol 175: 541–546.

51. RobersonED, Scearce-LevieK, PalopJJ, YanF, ChengIH, et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750–754.

52. FulgaTA, Elson-SchwabI, KhuranaV, SteinhilbML, SpiresTL, et al. (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9: 139–148.

53. IijimaK, GattA, Iijima-AndoK (2010) Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Hum Mol Genet 19: 2947–2957.

54. ThiesE, MandelkowEM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J Neurosci 27: 2896–2907.

55. MandelkowEM, ThiesE, TrinczekB, BiernatJ, MandelkowE (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 167: 99–110.

56. BallatoreC, LeeVM, TrojanowskiJQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8: 663–672.

57. DoerflingerH, VogtN, TorresIL, MirouseV, KochI, et al. (2003) Bazooka is required for polarisation of the Drosophila anterior-posterior axis. Development 137: 1765–1773.

58. WuPR, TsaiPI, ChenGC, ChouHJ, HuangYP, et al. (2011) DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity. Cell Death Differ 18: 1507–1520.

59. WangS, YangJ, TsaiA, KucaT, SannyJ, et al. (2011) Drosophila adducin regulates Dlg phosphorylation and targeting of Dlg to the synapse and epithelial membrane. Dev Biol 357: 392–403.

60. SchonEA, PrzedborskiS (2011) Mitochondria: the next (neurode)generation. Neuron 70: 1033–1053.

61. DietzlG, ChenD, SchnorrerF, SuKC, BarinovaY, et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151–156.

62. FeuilletteS, MiguelL, FrebourgT, CampionD, LecourtoisM (2010) Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. J Neurochem 113: 895–903.